Journal
BIOLOGICAL CHEMISTRY
Volume 391, Issue 9, Pages 1031-1040Publisher
WALTER DE GRUYTER GMBH
DOI: 10.1515/BC.2010.103
Keywords
cathepsin L; C/EBP alpha; ChIP assays; p53; promoter; real-time PCR; transcription.
Categories
Funding
- Department of Science and Technology, Government of India
- Indian Council of Medical Research (ICMR), New Delhi, India
Ask authors/readers for more resources
Mutations in the tumor suppressor gene p53 are frequent in human glioblastomas. Similarly cathepsin L, a lysosomal cysteine protease, is overexpressed and secreted by most human tumors including glioblastomas. However, hitherto there is no information on whether or not the mutation(s) in the p53 gene affect( s) expression of this protease. Using human glioblastoma cell lines harboring wild type and mutant p53, we demonstrate here for the first time that only the wild type but not the mutant p53 upregulates cathepsin L expression. By transfection of promoter reporter constructs, site-directed mutagenesis and chip assays we have established that wild type p53 elevates the levels of cathepsin L in these cells. It does so directly by binding to the cathepsin L promoter and also indirectly by inducing the expression of C/EBP alpha, which is crucial for the transcription of this protease. In view of its role in tumorigenesis, angiogenesis and tumor cell invasion, increased expression of cathepsin L in glioblastoma cells harboring wild type p53 might confer invasive ability and growth advantage to these cells. Therefore, use of cathepsin L inhibitors could prove useful in the management of these tumors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available